Trial
NCT04102436
Non-Viral TCR Gene Therapy
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Endocrine/Neuroendocrine
Intervention
Fludarabine
Why stopped
Difficulty with availability of GLP-grade reagents for manufacturing.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-12